May 2007
Volume 48, Issue 13
ARVO Annual Meeting Abstract  |   May 2007
Retinal Tolerance of DFPE, a Novel Perfluoro-Chemical
Author Affiliations & Notes
  • D. J. Keegan
    Ophthalmology, Mater Hospital (Institute of Ophthalmology), Dublin, Ireland
    Ophthalmology, Columbia Presbyterian Hospital, New York, New York
  • L. Vannozzi
    Ophthalmology, University of Forence, Firenze, Italy
  • B. Fuchs
    Ophthalmology, Columbia Presbyterian Hospital, New York, New York
  • R. Santos
    Ophthalmology, Columbia Presbyterian Hospital, New York, New York
  • S. Tari
    Ophthalmology, Columbia Presbyterian Hospital, New York, New York
  • N. Simpson
    Chemistry, University of Bristol, Bristol, United Kingdom
  • J. Sparrow
    Ophthalmology, Columbia Presbyterian Hospital, New York, New York
  • S. Chang
    Ophthalmology, Columbia Presbyterian Hospital, New York, New York
  • Footnotes
    Commercial Relationships D.J. Keegan, None; L. Vannozzi, None; B. Fuchs, None; R. Santos, None; S. Tari, None; N. Simpson, Bristol, P; J. Sparrow, None; S. Chang, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 5741. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D. J. Keegan, L. Vannozzi, B. Fuchs, R. Santos, S. Tari, N. Simpson, J. Sparrow, S. Chang; Retinal Tolerance of DFPE, a Novel Perfluoro-Chemical. Invest. Ophthalmol. Vis. Sci. 2007;48(13):5741.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose:: The development of perfluorocarbon liquid as an intraoperative tool during vitreoretinal surgery has been a valuable addition to the surgical management of complicated retinal detachment. Nevertheless, there remains a need for substances that can be left in the eye postsurgically. High-density perfluorocarbon liquids in current use are not appropriate because of rapid dispersion into small droplets and potential toxicity. We have tested retinal tolerance to a novel medium density liquid - DFPE - a partially fluorinated 10-carbon material.

Methods:: Thirteen (13) rabbits underwent two-port 25 gauge mechanical vitrectomy. In 9 rabbits, DFPE (0.8-1.2 ml) was placed in the vitreous cavity of one eye; 4 rabbits with balanced salt solution, served as control.Eyes were followed ophthalmoscopically and electroretinographic recordings were obtained pre-operatively (baseline) and at 1, 3 and 6 months postoperatively. Enucleation was carried out at 6 months and histological evaluation completed on 2 eyes.

Results:: On examination, it was determined that vitreous fills with DFPE reached 50% in 4 eyes and 20-50% in 4 eyes. DFPE appeared to be well tolerated with just mild vitreous inflammation in 2 eyes and greater inflammation in 2 eyes. Dispersion of the fluid appeared 2 weeks postoperatively and for the remainder of follow-up globule size remained stable. Posterior subcapsular cataracts were noted in eyes with large fills of DFPE. Cellular debris was observed at the interface between DFPE and physiological fluid in 6 of 9 eyes and this remained unchanged for 6 months.With ERG recording at 1, 3 and 6 months postoperatively, there was no effect on the latency and amplitude of the A-wave as compared to saline-injected eyes or fellow non-operated control eyes. B wave amplitudes, however, were increased at 1, 3 and 6 months. Histological evaluation of 2 DFPE filled eyes after 6 months showed the presence of some giant cells on the surface of the retina. Thickening of the inner retina was observed inferiorly due to Muller cell hypertrophy. There was no loss of outer nuclear layer thickness but occasional photoreceptor nuclei dropout was observed.

Conclusions:: DFPE is relatively well tolerated but is prone to dispersion, mild intraocular inflammation and retinal changes over a prolonged period of time. Long-term studies will determine if these changes are reversible following removal of DFPE.

Keywords: vitreous substitutes • retinal detachment • proliferative vitreoretinopathy 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.